new glp retatrutide 🎙️ EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Gwyneth Paltrow, Andrew Huberman &

Source data Source Data Fig

But now, three GLP-1 medications are FDA-approved specifically for weight loss: liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)

Temperatures above 30 degrees Celsius (86F) cause rapid degradation

Why peptides are particularly challenging for sublingual delivery Peptides like semaglutide and tirzepatide are large molecules compared to many sublingual drugs

PlexusDx does not sell, prescribe, or recommend retatrutide or any other investigational peptide in this category

was supported in part by a graduate fellowship from the NSF (DGE-1747503) and by a Biotechnology Training Grant from NIGMS (T32 GM008349)